Skip to main content
Clinical Trials/NCT02515552
NCT02515552CompletedPhase 2

Web-Based Program for Symptom Management in Fibromyalgia

Collinge and Associates, Inc.1 site in 1 country883 target enrollmentStarted: September 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
883
Locations
1
Primary Endpoint
Change in daily symptom Levels

Study Overview

Brief Summary

Fibromyalgia is a complex chronic illness affecting 6-12 million Americans. Self-management strategies play a key role in reducing symptoms and maintaining functioning. The proposed project offers a web-based self management tool that enables FM sufferers to identify significant linkages between their personal symptom levels and their personal self-management efforts over time in order to plan their own optimal approach to disease management.

Detailed Description

This Phase II project will complete development of the SMART (Self-Monitoring and Review Tool) Log program for symptom management and health promotion in FM and evaluate its efficacy in a large web-based trial that will closely emulate its planned application in Phase III. The SMARTLog program is an interactive web-based self-monitoring and feedback intervention that employs proprietary statistical analysis procedures to give the user personally optimized guidance on behavioral, lifestyle and coping strategies that yield effective symptom reduction for that individual. The program incorporates longitudinal collection and analysis of the individual's self-monitoring data followed by delivery of personalized feedback derived from those same personal data. The program helps FM sufferers discover and monitor linkages between specific personal health-related behaviors and management strategies and their symptom levels over time. Feasibility was demonstrated in Phase I by very high retention rates, ratings of satisfaction and perceived relevance, evidence of impact of utilization on improved well-being over the use period, and qualitative data indicating strong interest in continuation with the program.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Masking
None

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Self-reported presence of fibromyalgia

Exclusion Criteria

  • Not provided

Arms & Interventions

All applicants

Other

Study applicants who consented and completed the application to participate in the Fibromyalgia Wellness Project. From that point forward all subjects used the intervention program to at whatever frequency they chose voluntarily. It was recommended subjects complete a SMARTLog at least three times per week for at least three months.

Intervention: The Fibromyalgia Wellness Project (Behavioral)

Outcomes

Primary Outcomes

Change in daily symptom Levels

Time Frame: Baseline to user-defined end date (variable time series design) up to 9 months

Change in Likert-scaled (0-10) daily symptom severity levels on the SMARTLog tracking instrument. Daily reported levels over multiple days are aggregated to calculate trends over the user-defined reporting period.

Secondary Outcomes

  • Change in Self-Efficacy for Chronic Disease Scale scores(Baseline to user-defined end date (variable time series design) up to 9 months)
  • Change in Fibromyalgia Impact Questionnaire scores(Baseline to user-defined end date (variable time series design) up to 9 months)
  • Change in SF12 scores(Baseline to user-defined end date (variable time series design) up to 9 months)
  • Change in Multi-dimensional Health Locus of Control Scale scores(Baseline to user-defined end date (variable time series design) up to 9 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

William Collinge, PhD

President

Collinge and Associates, Inc.

Study Sites (1)

Loading locations...

Similar Trials